IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Elmind Capital, LP

Portfolio Profile

CIK: 0002052213 | NEW YORK, NY

Investment Profile

Style

Value

Turnover

High

Orientation

Concentrated trader
$398.0M
AUM
35
Positions
66.6%
Top 10 Conc.
96.13%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Cogent Biosciences Inc(COGT)1,170,740$45.3M11.38%
2Syndax Pharmaceuticals Inc(SNDX)1,855,000$40.6M10.19%
3Celldex Therapeutics Inc New(CLDX)990,000$36.8M9.25%
4Relay Therapeutics Inc(RLAY)1,465,279$27.4M6.89%
5Vaxcyte Inc(PCVX)452,340$26.3M6.61%

Sector Allocation

Latest filing, equity positions only

Healthcare94.06% · $374.4M
Unclassified5.94% · $23.6M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare94.7%94.06%-0.64%
Unclassified5.3%5.94%+0.64%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$338.9M | 34 pos.
$352.2M | 34 pos.
$398.0M | 35 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

5
New
4
6
Vera Therapeutics Inc(VERA)
436,518
$18.7M
4.71%
7Pharvaris N V(PHVS)525,750$18.2M4.57%
8Viridian Therapeutics Inc(VRDN)984,931$18.1M4.55%
9Cytomx Therapeutics Inc.(CTMX)4,550,000$17.1M4.29%
10Travere Therapeutics Inc(TVTX)292,600$16.6M4.18%
Cap SizePrev %Curr %Change
Mid Cap60.15%56.28%-3.87%
Small Cap30.71%30.97%+0.26%
Large Cap3.28%6.27%+2.99%
Unclassified5.3%5.94%+0.64%
Micro Cap0.55%0.55%0%
Closed
9
Increased
6
Decreased
15
Unchanged